PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 9, 2026Environmental Health Perspectives0 citationsOpen Access

In Utero Per- and Polyfluoroalkyl Substances (PFAS) Exposure and Changes in Infant T Helper Cell Development among UPSIDE-ECHO Cohort Participants

View Full Paper
DCDarline Castro-MeléndezNLNathan LaniewskiTJTodd Jusko

Key Points

  • This research aims to understand how in utero exposure to PFAS affects the development of T-helper cell subpopulations in infants.
  • Maternal-infant dyads were recruited during the first trimester from 2015 to 2019.
  • PFAS levels were measured in maternal serum using high-performance liquid chromatography.
  • Infant lymphocyte frequencies were analyzed using mass cytometry at birth, 6, and 12 months.
  • In utero PFAS exposure correlated with changes in CD4+ T-cell subpopulations, notably T follicular helper and T-helper 2 cells.
  • A log2-unit increase in PFOS was associated with a 0.17% decrease in Tfh cell percentages and a 0.27% increase in Th2 cell percentages at 12 months.
  • Similar trends were confirmed for PFOA, PFNA, PFHXS, and PFDA.

Abstract

BACKGROUND: Environmental exposures to toxicants, such as per- and polyfluoroalkyl substances (PFAS), during gestation can disrupt immune development, causing long-term impacts on a child’s ability to generate a well-regulated, protective immune response. T-cells coordinate with all immune cell types to orchestrate both cellular and antibody-mediated responses. While there is compelling evidence that PFAS alters immunity in humans, the specific effects of early life PFAS exposure on infant T-cell development are unreported. Because of their central role in immunity, altered T-cell development in infants would have implications on immune responses broadly and long-term. OBJECTIVES: We seek to model longitudinal changes in the frequency of functionally distinct CD4+ T-cell subpopulations from birth through 12 months and their association with in utero PFAS exposure. METHODS: Maternal-infant dyads were recruited as part of the UPSIDE-ECHO cohort during the first trimester between 2015 and 2019 in Rochester, New York; dyads were followed through the infant’s first birthday. Maternal PFAS concentrations (PFOS, PFOA, PFNA, PFHXS and PFDA) were quantified in serum during the second trimester using high-performance liquid chromatography and tandem mass spectrometry. Infant lymphocyte frequencies were assessed at birth, 6- and 12-months using mass cytometry and high-dimensional clustering methods. Linear mixed-effects models were employed to analyze the relationship between maternal PFAS concentrations and CD4+ T-cell subpopulations (n = 200). All models included a PFAS and age interaction and were adjusted for parity, infant sex, and prepregnancy body mass index. RESULTS: In utero PFAS exposure correlated with multiple CD4+ T-cell subpopulations in infants. The greatest effect sizes were seen in T follicular helper (Tfh) and T-helper 2 (Th2) cells at 12 months. A log2-unit increase in PFOS was associated with lower Tfh 0.17% (95% CI: −0.30, −0.40) and greater Th2 0.27% (95% CI: 0.18, 0.35) cell percentages at 12 months. Similar trends were observed for PFOA, PFNA, PFHXS, and PFDA. DISCUSSION: Maternal PFAS exposures correlate with cell-specific changes in the infant T-cell compartment, including key CD4+ T-cell subpopulations that play central roles in coordinating well-regulated protective immunity. Future studies into the role of PFAS-associated T-cell distribution and the risk of adverse immune-related health outcomes in children are warranted.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Castro-Meléndez et al. (2026) studied this question.

synapsesocial.com/papers/69fecf49b9154b0b82876449https://doi.org/10.1021/ehp.6c00037
Ask AI
Helpful
Bookmark
Share
View Full Paper